Nan Fung Group Holdings LTD Fibrogen Inc Transaction History

Nan Fung Group Holdings LTD

  • $103 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$2.49 - $20.59 $69,720 - $576,520
28,000 Added 82.1%
62,106 $167,000
Q4 2022

Feb 13, 2023
BUY
$13.27 - $17.73 $256,774 - $343,075
19,350 Added 131.13%
34,106 $546,000
Q1 2022

May 13, 2022
BUY
$12.02 - $16.79 $177,367 - $247,753
14,756 New
14,756 $177,000

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Nan Fung Group Holdings LTD Portfolio

Follow Nan Fung Group Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Group Holdings LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email